(Q37609401)

21 August 2017

title

Pneumococcal polysaccharide vaccine: cost-effectiveness recommendations in adults (English)

1 reference

cost-effectiveness analysis

21 August 2017

1 reference

1 reference

Pedro Plans-Rubió

1

1 reference

21 August 2017

publication date

1 October 2005

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

541-551

1 reference

Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Pneumococcal vaccination: current and future issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

The cost effectiveness of pneumococcal vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Economic evaluations of adult pneumococcal vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Protective Efficacy of Pneumococcal Polysaccharide Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Pneumonia in HIV-infected patients: a case-control survey of factors involved in risk and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Pneumococcal vaccine. Efficacy and associated cost savings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.5.5.541

21 January 2018

Identifiers

DOI

10.1586/14737167.5.5.541

1 reference

21 August 2017

1 reference